Explore journal overview, editorial leadership, indexing, articles in press, latest published work, and highlights from previous issues.
Cancer
immunotherapy is the artificial stimulation of the immune system to treat
cancer to improving the adoptive immune system to fight cancer. It exploits the
fact that cancer cells often have molecules on their surface that can be
detected by the immune
system, known as tumor
antigens; they are often proteins or other macromolecules (e.g.
carbohydrates). Immunotherapies can be categorized as active, passive,Active
immunotherapy directs the immune system to attack tumor cells by targeting
tumor antigens. Passive
immunotherapies enhance existing anti-tumor
responses and include the use of monoclonal antibodies, lymphocytes and
cytokines.
Antibodies are proteins produced by the immune system that bind to a target
antigen on the cell surface. The immune system normally uses them to fight
pathogens. Each antibody is specific to one or a few proteins. Those that bind
to tumor
antigens treat cancer.
Edelweiss: Cancer Open Access is an open access journal which aims to publish most complete and genuine source of information in the form of short commentary, mini review, case report, related, but not limited to above areas and making them available freely through online without any subscriptions and restrictions to researches worldwide
Researchers, authors, reviewers, and readers can use this page to find journal resources connected with Cancer immunotherapy, including published articles, related academic topics, current issue content, archive material, and manuscript submission information.
Prostate cancer is the most prevalent and second cause of death from cancer in men worldwide. Immunotherapy is a new method for the treatment of several cancers that fights cancer cells by...
